SanBio Co. Ltd.

SanBio Co. Ltd.
Stock Exchange Other OTC
EPS
$0.51
Market Cap
$1.65 B
Shares Outstanding
49.7 M
Public Float
-
SanBio Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY56.69
Market Cap
JPY182.36 B
Shares Outstanding
51.73 M
Public Float
26.71 M

Profile

Address
St. Luke Tower, 28/F
Tokyo Tokyo 104
Japan
Employees -
Website http://www.sanbio.jp
Updated 07/08/2019
SanBio Co., Ltd. engages in the development and sale of regenerative cells pharmaceuticals. It also provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded by Keita Mori and Toru Kawanishi in February 2001 and is headquartered in Tokyo, Japan.

Financials

View All
Created with Highcharts 5.0.14SanBio Co. Ltd.Net Income. Fiscal year is February-January. All values JPY Millions.5895891 7361 7369889881 8351 8353 9403 9402 9212 92120142015201620172018201901k2k3k4k5k
Created with Highcharts 5.0.14SanBio Co. Ltd.Sales/Revenue. Fiscal year is February-January. All values JPY Millions.2042043 2293 2291 1751 17595095049149174274220142015201620172018201901k2k3k4k

Toru Kawanishi
Chairman
Keita Mori
President & Representative Director